Status:

COMPLETED

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Lead Sponsor:

Intergroupe Francophone de Cancerologie Thoracique

Collaborating Sponsors:

Roche Pharma AG

GFPC

Conditions:

Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

CLINATEZO cohort will evaluate overall survival, real world progression-free survival, best response and duration of treatment in patients with advanced, metastatic Small Cell Lung Cancer (SCLC) who r...

Detailed Description

Standard-of-care first-line treatment for advanced, metastatic Small Cell Lung Cancer is platinum chemotherapy (carboplatin or cisplatin) with etoposide. Despite response rates of 60 to 65%, limited p...

Eligibility Criteria

Inclusion

  • Patients with histologically or cytologically confirmed extensive stage Small Cell Lung Cancer at time of initiation of treatment with atezolizumab and chemotherapy.
  • Patients who were informed about the study and accepted for their data to be collected.
  • Patients who received at least one dose of treatment with atezolizumab and chemotherapy as part of the French Early Access Program (ATU program) and have been accepted within this ATU program
  • Selection period spans from May 6th 2019 until January 31st 2020 for initiation of treatment with atezolizumab and chemotherapy.

Exclusion

  • Patients enrolled in a clinical trial assessing treatment with a combination of atezolizumab and chemotherapy. (ATU was granted to patients unable to meet eligibility criteria for on-going recruiting trials, unable to participate to other clinical trials, or because other medical interventions were not considered appropriate or acceptable).
  • Patients who were included in the French Early Access Program (ATU program) but did not receive any atezolizumab and chemotherapy treatment.

Key Trial Info

Start Date :

February 2 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2024

Estimated Enrollment :

518 Patients enrolled

Trial Details

Trial ID

NCT04920981

Start Date

February 2 2021

End Date

September 1 2024

Last Update

November 7 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Chalon-sur-Saône - CH

Chalon-sur-Saône, France

2

Paris - Institut Curie

Paris, France